| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
| | FI | PI | | Endoxan 1 g | Durchstechflasche(n) | 20.30 | 38.50 | 10% | | Lyophilisat: Cyclophosphamidum Anhydricum 1000 mg | Baxter AG | A / SL | FB | | G |  |
| | FI | PI | | Endoxan 200 mg | Durchstechflasche(n) | 4.15 | 13.75 | 10% | | Trockensubstanz: Cyclophosphamidum Anhydricum 200 mg | Baxter AG | A / SL | FB | | G |  |
| | FI | PI | | Endoxan 500 mg | Durchstechflasche(n) | 10.30 | 27.60 | 10% | | Trockensubstanz: Cyclophosphamidum Anhydricum 500 mg | Baxter AG | A / SL | FB | | G |  |
| | FI | PI | | Endoxan - T | 50 Dragée(s) | 14.87 | 32.60 | 10% | | Dragées: Cyclophosphamidum Anhydricum 50 mg | Baxter AG | A / SL | FB | | G |  |
|
| | FI | PI | | Leukeran | 25 Tablette(n) | 19.80 | 37.95 | 10% | | Filmtabletten: Chlorambucilum 2 mg | Aspen Pharma Schweiz GmbH | A / SL | FB | | G |  |
|
L | | FI | PI | | Alkeran | Durchstechflasche(n) | 72.49 | 94.35 | 10% | | Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung: Melphalanum 50 mg | Aspen Pharma Schweiz GmbH | A / SL / SO | FB | | G |  |
L | | FI | | | Melphalan Ideogen 50 mg | | 57.99 | 79.50 | 10% | | | Ideogen AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Alkeran 2 mg | 25 Tablette(n) | 29.26 | 48.25 | 10% | | Filmtabletten: Melphalanum 2 mg | Aspen Pharma Schweiz GmbH | A / SL | FB | | G |  |
| | FI | | | Phelinun 50 mg | 1 + | PA | PA | k.A. | | polvere e solvente per concentrato per soluzione per infusione: Melphalanum 50 mg | Adienne SA | A | FB | | G |  |
| | FI | | | Phelinun 200 mg | 1 + | PA | PA | k.A. | | polvere e solvente per concentrato per soluzione per infusione: Melphalanum 200 mg | Adienne SA | A | FB | | G |  |
|
L | | FI | PI | | Ledaga | 60 g | 1538.38 | 1689.50 | 10% | | Gel: Chlormethinum 160 µg | Recordati AG | A / SL | FB | | G |  |
|
| | FI | | | Holoxan 500 mg | Durchstechflasche(n) | 24.57 | 43.15 | 10% | | Trockensubstanz: Ifosfamidum 500 mg | Baxter AG | A / SL | FB | | G |  |
| | FI | | | Holoxan 1 g | Durchstechflasche(n) | 42.26 | 62.40 | 10% | | Trockensubstanz: Ifosfamidum 1 g | Baxter AG | A / SL | FB | | G |  |
| | FI | | | Holoxan 2 g | Durchstechflasche(n) | 78.62 | 101.90 | 10% | | Trockensubstanz: Ifosfamidum 2 g | Baxter AG | A / SL | FB | | G |  |
|
L | KFI | FI | | | Ribomustin 25 mg | Durchstechflasche(n) | 58.04 | 79.20 | 10% | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 25 mg | CPS Cito Pharma Services GmbH | A / SL / SO | FB | | G |  |
L | KFI | FI | | | Ribomustin 25 mg | 5 Durchstechflasche(n) | 241.17 | 277.35 | 10% | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 25 mg | CPS Cito Pharma Services GmbH | A / SL / SO | FB | | G |  |
L | KFI | FI | | | Ribomustin 100 mg | Durchstechflasche(n) | 187.85 | 219.65 | 10% | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 100 mg | CPS Cito Pharma Services GmbH | A / SL / SO | FB | | G |  |
L | | FI | | | Bendamustin Accord 25 mg | | 52.76 | 73.80 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Bendamustini Hydrochloridum 25 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
L | | FI | | | Bendamustin Accord 25 mg | 5 | 219.25 | 254.85 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Bendamustini Hydrochloridum 25 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
L | | FI | | | Bendamustin Accord 100 mg | | 170.78 | 202.15 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Bendamustini Hydrochloridum 100 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
L | | FI | | | Bendamustin Sandoz 25 mg | | 52.76 | 73.80 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Bendamustini Hydrochloridum 25 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
L | | FI | | | Bendamustin Sandoz 25 mg | 5 | 219.25 | 254.85 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Bendamustini Hydrochloridum 25 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
L | | FI | | | Bendamustin Sandoz 100 mg | | 170.78 | 202.15 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Bendamustini Hydrochloridum 100 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | | | | Bendamustin Accord liquid 100 mg/4 ml | | PA | PA | k.A. | | Infusionskonzentrat: Bendamustinum 100 mg | Accord Healthcare AG | A | FB | | G |  |
| | | | | Bendamustin Accord liquid 100 mg/4 ml | 5 | PA | PA | k.A. | | Infusionskonzentrat: Bendamustinum 100 mg | Accord Healthcare AG | A | FB | | G |  |
| KFI | FI | | | Ribomustin 25 mg | 10 Durchstechflasche(n) | PA | PA | k.A. | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 25 mg | CPS Cito Pharma Services GmbH | A | FB | | G |  |
| KFI | FI | | | Ribomustin 25 mg | 20 Durchstechflasche(n) | PA | PA | k.A. | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 25 mg | CPS Cito Pharma Services GmbH | A | FB | | G |  |
| KFI | FI | | | Ribomustin 100 mg | 5 Durchstechflasche(n) | PA | PA | k.A. | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 100 mg | CPS Cito Pharma Services GmbH | A | FB | | G |  |
| | FI | | | Bendamustin Accord 100 mg | 5 | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Bendamustini Hydrochloridum 100 mg | Accord Healthcare AG | A | FB | | G |  |
| | FI | | | Bendamustin Sandoz 25 mg | 10 | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Bendamustini Hydrochloridum 25 mg | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | | | Bendamustin Sandoz 25 mg | 20 | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Bendamustini Hydrochloridum 25 mg | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | | | Bendamustin Sandoz 100 mg | 5 | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Bendamustini Hydrochloridum 100 mg | Sandoz Pharmaceuticals AG | A | FB | | G |  |
|
L | | FI | | | Trecondi 1 g | | 114.23 | 140.65 | 10% | | Lyophilisat: Treosulfanum 1 g | Ideogen AG | A / SL | FB | | G |  |
L | | FI | | | Trecondi 5 g | | 548.76 | 613.25 | 10% | | Lyophilisat: Treosulfanum 5 g | Ideogen AG | A / SL | FB | | G |  |
|
| | FI | | | TEPADINA 200 mg | | PA | PA | k.A. | | polvere e solvente per soluzione per infusione: Thiotepum 200 mg | Adienne SA | A | FB | | G |  |
| | FI | | | TEPADINA 400 mg | | PA | PA | k.A. | | polvere e solvente per soluzione per infusione: Thiotepum 400 mg | Adienne SA | A | FB | | G |  |
| | FI | | | Tepadina 15 mg | Flasche(n) | PA | PA | k.A. | | polvere per soluzione per infusione: Thiotepum 15 mg | Adienne SA | A | FB | | G |  |
| | FI | | | Tepadina 100 mg | Flasche(n) | PA | PA | k.A. | | polvere per soluzione per infusione: Thiotepum 100 mg | Adienne SA | A | FB | | G |  |
| | FI | | | Thiotepa Lederle | 15 mg | PA | 27.40 | k.A. | | Injektionspräparat: Thiotepum 15 mg | AHP (Schweiz) AG | A | FB | | G |  |
|
| | FI | | | BiCNU 100 mg | 2 | PA | PA | k.A. | | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung: Carmustinum 100 mg | Ideogen AG | A | FB | | G |  |
|
| | FI | PI | | Temodal 5 mg | 5 Kapsel(n) | 10.53 | 27.85 | 10% | | Kapseln: Temozolomidum 5 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temodal 5 mg | 20 Kapsel(n) | 42.19 | 62.05 | 10% | | Kapseln: Temozolomidum 5 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temodal 20 mg - T | 5 Kapsel(n) | 40.71 | 60.75 | 10% | | Kapseln: Temozolomidum 20 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temodal 20 mg - T | 20 Kapsel(n) | 163.05 | 192.85 | 10% | | Kapseln: Temozolomidum 20 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temodal 100 mg - T | 5 Kapsel(n) | 195.71 | 228.15 | 10% | | Kapseln: Temozolomidum 100 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temodal 100 mg - T | 20 Kapsel(n) | 782.84 | 858.20 | 10% | | Kapseln: Temozolomidum 100 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temodal 140 mg | 5 Kapsel(n) | 299.01 | 341.20 | 10% | | Kapseln: Temozolomidum 140 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temodal 140 mg | 20 Kapsel(n) | 1196.02 | 1307.00 | 10% | | Kapseln: Temozolomidum 140 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temodal 180 mg | 5 Kapsel(n) | 350.85 | 396.00 | 10% | | Kapseln: Temozolomidum 180 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temodal 180 mg | 20 Kapsel(n) | 1403.43 | 1534.90 | 10% | | Kapseln: Temozolomidum 180 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temodal 250 mg - T | 5 Kapsel(n) | 489.52 | 546.05 | 10% | | Kapseln: Temozolomidum 250 mg | MSD Merck Sharp & Dohme AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Temozolomid Accord 5 mg | 5 | 10.45 | 27.80 | 10% | | Kapseln: Temozolomidum 5 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid Accord 5 mg | 20 | 38.36 | 58.15 | 10% | | Kapseln: Temozolomidum 5 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 20 mg | 5 | 41.80 | 61.85 | 10% | | Kapseln: Temozolomidum 20 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 20 mg | 20 | 148.23 | 177.65 | 10% | | Kapseln: Temozolomidum 20 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 100 mg | 5 | 177.92 | 209.90 | 10% | | Kapseln: Temozolomidum 100 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 100 mg | 20 | 626.90 | 698.20 | 10% | | Kapseln: Temozolomidum 100 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 140 mg | 5 | 292.63 | 334.65 | 10% | | Kapseln: Temozolomidum 140 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 140 mg | 20 | 1031.11 | 1137.80 | 10% | | Kapseln: Temozolomidum 140 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 180 mg | 5 | 318.96 | 363.30 | 10% | | Kapseln: Temozolomidum 180 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 180 mg | 20 | 1275.85 | 1404.00 | 10% | | Kapseln: Temozolomidum 180 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Accord 250 mg | 5 | 445.02 | 500.40 | 10% | | Kapseln: Temozolomidum 250 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid Devatis 5 mg | 5 | 10.45 | 27.80 | 10% | | Kapseln: Temozolomidum 5 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid Devatis 5 mg | 20 | 38.36 | 58.15 | 10% | | Kapseln: Temozolomidum 5 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Devatis 20 mg | 5 | 41.80 | 61.85 | 10% | | Kapseln: Temozolomidum 20 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Devatis 20 mg | 20 | 148.23 | 177.65 | 10% | | Kapseln: Temozolomidum 20 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Devatis 100 mg | 5 | 177.92 | 209.90 | 10% | | Kapseln: Temozolomidum 100 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Devatis 100 mg | 20 | 626.91 | 698.20 | 10% | | Kapseln: Temozolomidum 100 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Devatis 140 mg | 5 | 292.63 | 334.65 | 10% | | Kapseln: Temozolomidum 140 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Devatis 140 mg | 20 | 1031.13 | 1137.85 | 10% | | Kapseln: Temozolomidum 140 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Devatis 180 mg | 5 | 318.96 | 363.30 | 10% | | Kapseln: Temozolomidum 180 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Devatis 180 mg | 20 | 1275.86 | 1404.00 | 10% | | Kapseln: Temozolomidum 180 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Devatis 250 mg | 5 | 445.03 | 500.40 | 10% | | Kapseln: Temozolomidum 250 mg | Devatis AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 5 mg | 5 Kapsel(n) | 10.45 | 27.80 | 10% | | Kapseln: 2 Wirkstoffe | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 20 mg | 5 Kapsel(n) | 41.08 | 61.10 | 10% | | Kapseln: 2 Wirkstoffe | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 100 mg | 5 Kapsel(n) | 177.92 | 209.90 | 10% | | Kapseln: 2 Wirkstoffe | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 140 mg | 5 Kapsel(n) | 292.63 | 334.65 | 10% | | Kapseln: 2 Wirkstoffe | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 180 mg | 5 Kapsel(n) | 318.96 | 363.30 | 10% | | Kapseln: 2 Wirkstoffe | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 5 mg | 20 Kapsel(n) | 38.36 | 58.15 | 10% | | Kapseln: 2 Wirkstoffe | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 20 mg | 20 Kapsel(n) | 148.23 | 177.65 | 10% | | Kapseln: 2 Wirkstoffe | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 140 mg | 20 Kapsel(n) | 1031.11 | 1137.80 | 10% | | Kapseln: 2 Wirkstoffe | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 180 mg | 20 Kapsel(n) | 1275.85 | 1404.00 | 10% | | Kapseln: 2 Wirkstoffe | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 250 mg | 5 Kapsel(n) | 445.02 | 500.40 | 10% | | Kapseln: Temozolomidum 250 mg | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | | | Temozolomid Devatis 250 mg | 20 | PA | PA | k.A. | | Kapseln: Temozolomidum 250 mg | Devatis AG | A | FB | | G |  |
| | FI | PI | | Temozolomid-Teva 100 mg | 20 Kapsel(n) | PA | PA | k.A. | | Kapseln: 2 Wirkstoffe | Teva Pharma AG | A | FB | | G |  |
|
| | FI | | | Dacin 500 mg | | PA | PA | k.A. | | Lyophilisat: Dacarbazinum 500 mg | Lipomed AG | A | FB | | G |  |
| | FI | | | Dacin 1000 mg | | PA | PA | k.A. | | Lyophilisat: Dacarbazinum 1000 mg | Lipomed AG | A | FB | | G |  |
| | FI | | | Dacin 200 mg | 10 | 165.10 | 195.95 | 10% | | Lyophilisat: Dacarbazinum 200 mg | Lipomed AG | A / SL / SG | FB | | G |  |
| | FI | | | DTIC-Dome 200 mg | 12 Ampulle(n) | 289.00 | 356.70 | k.A. | | Injektionspräparat: Dacarbazinum 200 mg | Medinova AG | A | FB | | G |  |